Sabar Karimah Es Sells Common Stock and Stock Options
2026-04-03SEC Filing 4 (0001873796-26-000006)
On April 2, 2026, Sabar Karimah Es, a director at CAPRICOR THERAPEUTICS, INC. (CAPR), reported a series of transactions. Es sold 7,529 shares of Common Stock at $32.00 per share, acquired through a 10b5-1 trading plan. Concurrently, Es acquired 7,529 shares of Common Stock at $3.18 per share. Additionally, Es disposed of a stock option (right to buy) with an exercise price of $3.18, which vested monthly starting February 1, 2022. Following these transactions, Es holds 0 shares of Common Stock and 161 stock options. The reporting owner is Sabar Karimah Es, with the filing represented by Linda Marban as Power of Attorney.